Conference
P2.07-029 CheckMate 169: Safety/Efficacy of Nivolumab in Canadian Pretreated Advanced NSCLC (including Elderly and PS 2) Patients
Authors
Juergens R; Chu Q; Rothenstein J; De Angelis F; Banerji S; Marquis K; Sauciuc D; Begin P; Finn N; Hirsh V
Volume
12
Pagination
pp. s2426-s2427
Publisher
Elsevier
Publication Date
November 2017
DOI
10.1016/j.jtho.2017.11.088
Conference proceedings
Journal of Thoracic Oncology
Issue
11
ISSN
1556-0864